| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Whipple Disease | 5 | 2018 | 38 | 2.18 | Why? |
| Gastrointestinal Microbiome | 15 | 2020 | 1961 | 2.14 | Why? |
| Tropheryma | 4 | 2018 | 28 | 1.73 | Why? |
| Bacteria | 8 | 2019 | 1897 | 1.57 | Why? |
| Microbiota | 6 | 2019 | 1240 | 1.28 | Why? |
| Sodium Chloride | 2 | 2018 | 203 | 1.26 | Why? |
| Bacteriological Techniques | 3 | 2018 | 239 | 1.23 | Why? |
| Clostridium Infections | 8 | 2019 | 595 | 1.10 | Why? |
| Azithromycin | 15 | 2021 | 3943 | 1.03 | Why? |
| Metagenomics | 8 | 2019 | 823 | 1.00 | Why? |
| Fecal Microbiota Transplantation | 5 | 2020 | 372 | 0.99 | Why? |
| Measles | 2 | 2019 | 608 | 0.85 | Why? |
| Firmicutes | 2 | 2018 | 41 | 0.78 | Why? |
| Listeriosis | 1 | 2019 | 36 | 0.78 | Why? |
| Culture Techniques | 1 | 2018 | 36 | 0.75 | Why? |
| Bacillaceae | 1 | 2018 | 10 | 0.74 | Why? |
| Hydroxychloroquine | 16 | 2021 | 12447 | 0.69 | Why? |
| Giant Viruses | 1 | 2017 | 27 | 0.69 | Why? |
| Industrial Development | 1 | 2017 | 29 | 0.68 | Why? |
| Self-Examination | 1 | 2017 | 30 | 0.68 | Why? |
| Vaginosis, Bacterial | 1 | 2017 | 51 | 0.66 | Why? |
| Feces | 8 | 2020 | 4235 | 0.65 | Why? |
| Spores, Bacterial | 1 | 2016 | 45 | 0.65 | Why? |
| West Nile Fever | 1 | 2019 | 166 | 0.64 | Why? |
| France | 28 | 2021 | 12074 | 0.62 | Why? |
| Vitamin A | 1 | 2017 | 188 | 0.62 | Why? |
| Microbiological Techniques | 2 | 2020 | 232 | 0.59 | Why? |
| Travel Medicine | 1 | 2019 | 335 | 0.58 | Why? |
| Metagenome | 1 | 2016 | 268 | 0.55 | Why? |
| Genome, Bacterial | 4 | 2019 | 446 | 0.55 | Why? |
| Vagina | 1 | 2017 | 327 | 0.55 | Why? |
| Cell Culture Techniques | 1 | 2018 | 704 | 0.51 | Why? |
| Drug Resistance, Multiple, Bacterial | 3 | 2018 | 1115 | 0.48 | Why? |
| Base Composition | 5 | 2019 | 203 | 0.48 | Why? |
| DNA, Bacterial | 8 | 2019 | 835 | 0.46 | Why? |
| RNA, Ribosomal, 16S | 7 | 2019 | 793 | 0.45 | Why? |
| Abortion, Spontaneous | 1 | 2017 | 776 | 0.44 | Why? |
| Probiotics | 1 | 2019 | 694 | 0.44 | Why? |
| Bacterial Typing Techniques | 5 | 2018 | 273 | 0.44 | Why? |
| Ribavirin | 1 | 2017 | 1182 | 0.42 | Why? |
| Anti-Bacterial Agents | 12 | 2021 | 10083 | 0.41 | Why? |
| Sexually Transmitted Diseases | 1 | 2017 | 694 | 0.38 | Why? |
| Antimicrobial Stewardship | 1 | 2017 | 931 | 0.37 | Why? |
| Fatty Acids | 3 | 2018 | 238 | 0.36 | Why? |
| Staphylococcus lugdunensis | 2 | 2017 | 14 | 0.34 | Why? |
| Antiviral Agents | 11 | 2021 | 41703 | 0.34 | Why? |
| Arthritis | 1 | 2009 | 288 | 0.29 | Why? |
| Bacterial Infections | 1 | 2018 | 2229 | 0.27 | Why? |
| Humans | 92 | 2021 | 930598 | 0.27 | Why? |
| Prosthesis-Related Infections | 2 | 2017 | 302 | 0.25 | Why? |
| Endocarditis, Bacterial | 2 | 2018 | 344 | 0.25 | Why? |
| Immunologic Factors | 1 | 2019 | 4206 | 0.24 | Why? |
| Diagnostic Errors | 1 | 2009 | 865 | 0.24 | Why? |
| Zoonoses | 1 | 2017 | 3034 | 0.24 | Why? |
| Archaea | 2 | 2019 | 30 | 0.24 | Why? |
| Phylogeny | 10 | 2021 | 13341 | 0.23 | Why? |
| Disease Outbreaks | 5 | 2020 | 27595 | 0.23 | Why? |
| Polymerase Chain Reaction | 8 | 2020 | 6740 | 0.23 | Why? |
| Communicable Diseases | 1 | 2017 | 2148 | 0.23 | Why? |
| Intestines | 2 | 2018 | 817 | 0.22 | Why? |
| Contraindications | 1 | 2021 | 96 | 0.22 | Why? |
| Actinobacteria | 2 | 2018 | 87 | 0.22 | Why? |
| Ribotyping | 2 | 2018 | 54 | 0.22 | Why? |
| Enterocolitis, Pseudomembranous | 2 | 2018 | 93 | 0.22 | Why? |
| Drug Synergism | 5 | 2021 | 833 | 0.21 | Why? |
| RNA, Viral | 9 | 2021 | 32276 | 0.21 | Why? |
| Sequence Analysis, DNA | 6 | 2018 | 2830 | 0.21 | Why? |
| Microbial Consortia | 1 | 2019 | 20 | 0.20 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2018 | 449 | 0.20 | Why? |
| Clostridiales | 1 | 2019 | 24 | 0.20 | Why? |
| Fluorescent Antibody Technique, Indirect | 1 | 2020 | 393 | 0.19 | Why? |
| Specimen Handling | 1 | 2017 | 6190 | 0.19 | Why? |
| Angiotensin I | 1 | 2021 | 200 | 0.19 | Why? |
| Infectious Encephalitis | 1 | 2018 | 20 | 0.19 | Why? |
| Models, Statistical | 1 | 2017 | 5312 | 0.19 | Why? |
| Mesenteric Lymphadenitis | 1 | 2018 | 16 | 0.19 | Why? |
| Disease Management | 1 | 2017 | 6841 | 0.19 | Why? |
| Orthomyxoviridae | 2 | 2020 | 1168 | 0.19 | Why? |
| Madagascar | 1 | 2019 | 197 | 0.19 | Why? |
| Acinetobacter | 1 | 2018 | 58 | 0.19 | Why? |
| Haloferax | 1 | 2018 | 3 | 0.19 | Why? |
| Clostridium | 1 | 2018 | 33 | 0.19 | Why? |
| Genome, Archaeal | 1 | 2018 | 6 | 0.19 | Why? |
| Limbic Encephalitis | 1 | 2018 | 32 | 0.18 | Why? |
| Carnobacteriaceae | 1 | 2017 | 4 | 0.18 | Why? |
| DNA Barcoding, Taxonomic | 1 | 2018 | 39 | 0.18 | Why? |
| Internal Fixators | 1 | 2017 | 5 | 0.18 | Why? |
| Stomach | 1 | 2018 | 141 | 0.18 | Why? |
| Foot Bones | 1 | 2017 | 3 | 0.17 | Why? |
| Knee Prosthesis | 1 | 2017 | 40 | 0.17 | Why? |
| Pseudomonas | 1 | 2017 | 65 | 0.17 | Why? |
| Motorcycles | 1 | 2017 | 40 | 0.17 | Why? |
| Senegal | 1 | 2018 | 283 | 0.17 | Why? |
| Hip Prosthesis | 1 | 2017 | 54 | 0.17 | Why? |
| Staphylococcal Infections | 2 | 2017 | 1099 | 0.17 | Why? |
| Measles virus | 1 | 2019 | 194 | 0.17 | Why? |
| West Nile virus | 1 | 2019 | 206 | 0.17 | Why? |
| Arthritis, Infectious | 1 | 2018 | 111 | 0.17 | Why? |
| Electricity | 1 | 2017 | 68 | 0.17 | Why? |
| Male | 40 | 2021 | 367725 | 0.17 | Why? |
| Antibiosis | 1 | 2016 | 26 | 0.17 | Why? |
| Amino Acid Substitution | 2 | 2021 | 1706 | 0.17 | Why? |
| Horses | 1 | 2019 | 474 | 0.16 | Why? |
| Listeria monocytogenes | 1 | 2017 | 68 | 0.16 | Why? |
| Enterovirus | 1 | 2020 | 402 | 0.16 | Why? |
| Coxiella burnetii | 1 | 2017 | 120 | 0.16 | Why? |
| Travel | 4 | 2021 | 7220 | 0.16 | Why? |
| Adult | 32 | 2021 | 244371 | 0.16 | Why? |
| Breast | 1 | 2019 | 290 | 0.16 | Why? |
| Polymyxin B | 1 | 2017 | 93 | 0.16 | Why? |
| Carbapenem-Resistant Enterobacteriaceae | 1 | 2018 | 214 | 0.15 | Why? |
| Female | 41 | 2021 | 380317 | 0.15 | Why? |
| Doxycycline | 1 | 2018 | 307 | 0.15 | Why? |
| Coronavirus Infections | 18 | 2020 | 253789 | 0.15 | Why? |
| Meningitis | 1 | 2017 | 163 | 0.15 | Why? |
| Q Fever | 1 | 2017 | 130 | 0.15 | Why? |
| Aged, 80 and over | 22 | 2021 | 88759 | 0.15 | Why? |
| Aircraft | 1 | 2020 | 498 | 0.15 | Why? |
| Pneumonia, Viral | 16 | 2020 | 243684 | 0.15 | Why? |
| Repressor Proteins | 1 | 2017 | 232 | 0.15 | Why? |
| Mass Spectrometry | 2 | 2018 | 1165 | 0.15 | Why? |
| Angiotensin II | 1 | 2021 | 601 | 0.15 | Why? |
| Osteomyelitis | 1 | 2017 | 131 | 0.14 | Why? |
| Middle Aged | 33 | 2021 | 270681 | 0.14 | Why? |
| Aged | 30 | 2021 | 215776 | 0.14 | Why? |
| Whole Genome Sequencing | 3 | 2021 | 3239 | 0.14 | Why? |
| Sputum | 2 | 2020 | 1720 | 0.14 | Why? |
| High-Throughput Nucleotide Sequencing | 4 | 2021 | 3633 | 0.14 | Why? |
| Gram-Positive Bacterial Infections | 1 | 2018 | 323 | 0.14 | Why? |
| Colistin | 1 | 2017 | 217 | 0.14 | Why? |
| Betacoronavirus | 16 | 2020 | 204454 | 0.14 | Why? |
| Viral Load | 8 | 2021 | 15850 | 0.13 | Why? |
| Drug Combinations | 5 | 2021 | 3852 | 0.13 | Why? |
| Escherichia coli Infections | 1 | 2017 | 348 | 0.13 | Why? |
| Nose | 1 | 2020 | 1093 | 0.13 | Why? |
| Zinc | 1 | 2021 | 817 | 0.13 | Why? |
| Colon | 1 | 2018 | 669 | 0.13 | Why? |
| Gram-Negative Bacterial Infections | 1 | 2018 | 398 | 0.13 | Why? |
| Positron-Emission Tomography | 1 | 2018 | 802 | 0.13 | Why? |
| Saudi Arabia | 3 | 2019 | 4423 | 0.12 | Why? |
| Recurrence | 3 | 2018 | 3675 | 0.12 | Why? |
| Papillomaviridae | 1 | 2017 | 404 | 0.12 | Why? |
| Ageusia | 1 | 2021 | 918 | 0.12 | Why? |
| Enterobacteriaceae Infections | 1 | 2018 | 529 | 0.12 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.12 | Why? |
| Drug Therapy, Combination | 6 | 2021 | 7268 | 0.12 | Why? |
| Pharynx | 1 | 2020 | 1544 | 0.12 | Why? |
| Gastroenteritis | 1 | 2017 | 489 | 0.11 | Why? |
| Sequence Analysis, RNA | 1 | 2021 | 2290 | 0.11 | Why? |
| Infant | 8 | 2021 | 30274 | 0.11 | Why? |
| Antimalarials | 5 | 2021 | 2505 | 0.11 | Why? |
| Tuberculosis, Multidrug-Resistant | 1 | 2017 | 433 | 0.11 | Why? |
| Ecosystem | 1 | 2016 | 776 | 0.11 | Why? |
| Adolescent | 12 | 2021 | 86841 | 0.11 | Why? |
| Child, Preschool | 8 | 2021 | 36283 | 0.11 | Why? |
| Peptide Fragments | 1 | 2021 | 2075 | 0.10 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2020 | 1234 | 0.10 | Why? |
| Neoplasms | 1 | 2019 | 17251 | 0.10 | Why? |
| Treatment Outcome | 9 | 2021 | 51732 | 0.10 | Why? |
| Milk, Human | 1 | 2019 | 956 | 0.10 | Why? |
| Administration, Oral | 1 | 2017 | 2340 | 0.10 | Why? |
| Autoantibodies | 1 | 2021 | 2094 | 0.10 | Why? |
| Escherichia coli | 1 | 2017 | 1547 | 0.10 | Why? |
| Young Adult | 14 | 2021 | 93724 | 0.10 | Why? |
| Primary Prevention | 1 | 2017 | 778 | 0.10 | Why? |
| Islam | 1 | 2016 | 545 | 0.10 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2021 | 13720 | 0.10 | Why? |
| Animals | 5 | 2021 | 78931 | 0.10 | Why? |
| Vaccination Coverage | 1 | 2019 | 1249 | 0.10 | Why? |
| Hyperkalemia | 2 | 2021 | 140 | 0.10 | Why? |
| Coronavirus | 4 | 2020 | 18339 | 0.10 | Why? |
| Nasopharynx | 7 | 2021 | 10224 | 0.10 | Why? |
| Cell Phone | 1 | 2017 | 750 | 0.10 | Why? |
| Drug Interactions | 3 | 2021 | 1653 | 0.09 | Why? |
| Infant, Newborn | 5 | 2021 | 23105 | 0.09 | Why? |
| Microbial Sensitivity Tests | 1 | 2018 | 2886 | 0.09 | Why? |
| Communicable Disease Control | 2 | 2018 | 29620 | 0.09 | Why? |
| Hypokalemia | 2 | 2021 | 195 | 0.09 | Why? |
| Diagnostic Tests, Routine | 1 | 2020 | 2643 | 0.09 | Why? |
| Dietary Supplements | 1 | 2021 | 2251 | 0.09 | Why? |
| Bacterial Proteins | 1 | 2017 | 1318 | 0.09 | Why? |
| Infection Control | 1 | 2017 | 23131 | 0.09 | Why? |
| Genotype | 4 | 2021 | 4697 | 0.09 | Why? |
| Community-Acquired Infections | 2 | 2017 | 2328 | 0.09 | Why? |
| Interferon Type I | 1 | 2021 | 2789 | 0.09 | Why? |
| Influenza, Human | 3 | 2020 | 10779 | 0.09 | Why? |
| Influenza A virus | 1 | 2020 | 2234 | 0.09 | Why? |
| Africa | 1 | 2017 | 2986 | 0.09 | Why? |
| Virus Shedding | 2 | 2021 | 5834 | 0.08 | Why? |
| Oxygen | 1 | 2021 | 3715 | 0.08 | Why? |
| Obesity, Morbid | 1 | 2018 | 1340 | 0.08 | Why? |
| Viruses | 1 | 2020 | 2238 | 0.08 | Why? |
| Referral and Consultation | 2 | 2020 | 4816 | 0.08 | Why? |
| DNA, Viral | 1 | 2017 | 2521 | 0.08 | Why? |
| Long QT Syndrome | 3 | 2021 | 1047 | 0.08 | Why? |
| Genome, Viral | 4 | 2021 | 13157 | 0.08 | Why? |
| Proteomics | 1 | 2018 | 2481 | 0.08 | Why? |
| Abscess | 2 | 2019 | 234 | 0.08 | Why? |
| Clinical Laboratory Techniques | 4 | 2020 | 23402 | 0.08 | Why? |
| Clinical Protocols | 1 | 2017 | 2734 | 0.08 | Why? |
| Diarrhea | 1 | 2018 | 2743 | 0.08 | Why? |
| Mutation | 3 | 2021 | 12376 | 0.08 | Why? |
| Hypoxia | 1 | 2020 | 3626 | 0.07 | Why? |
| Poverty | 1 | 2017 | 2302 | 0.07 | Why? |
| Drug Repositioning | 5 | 2021 | 5683 | 0.07 | Why? |
| Child | 8 | 2021 | 70012 | 0.07 | Why? |
| Retrospective Studies | 10 | 2021 | 105322 | 0.07 | Why? |
| Liver Transplantation | 1 | 2020 | 2864 | 0.07 | Why? |
| Respiratory Tract Infections | 2 | 2016 | 6817 | 0.07 | Why? |
| Intensive Care Units | 5 | 2021 | 29594 | 0.07 | Why? |
| Acute Disease | 1 | 2017 | 6029 | 0.07 | Why? |
| Epidemiological Monitoring | 1 | 2017 | 3493 | 0.07 | Why? |
| Coinfection | 2 | 2020 | 6820 | 0.06 | Why? |
| Saliva | 1 | 2020 | 4679 | 0.06 | Why? |
| Point-of-Care Systems | 1 | 2017 | 2955 | 0.06 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2020 | 11367 | 0.06 | Why? |
| Electrocardiography | 3 | 2021 | 3957 | 0.06 | Why? |
| Survival Analysis | 3 | 2021 | 7592 | 0.06 | Why? |
| Genomics | 3 | 2019 | 3118 | 0.06 | Why? |
| Pandemics | 15 | 2020 | 389249 | 0.06 | Why? |
| Postoperative Complications | 1 | 2020 | 5861 | 0.06 | Why? |
| Developing Countries | 1 | 2017 | 4283 | 0.06 | Why? |
| Clinical Trials as Topic | 4 | 2021 | 7330 | 0.05 | Why? |
| Central African Republic | 1 | 2020 | 37 | 0.05 | Why? |
| Time-to-Treatment | 1 | 2018 | 5883 | 0.05 | Why? |
| Time Factors | 5 | 2021 | 31397 | 0.05 | Why? |
| Symbiosis | 1 | 2019 | 38 | 0.05 | Why? |
| Genome Size | 1 | 2019 | 38 | 0.05 | Why? |
| Mastitis | 1 | 2019 | 27 | 0.05 | Why? |
| DNA, Archaeal | 1 | 2018 | 7 | 0.05 | Why? |
| Biopsy | 2 | 2018 | 2811 | 0.05 | Why? |
| Cerebrum | 1 | 2018 | 17 | 0.05 | Why? |
| Colostrum | 1 | 2019 | 87 | 0.05 | Why? |
| Bacteroidetes | 1 | 2018 | 36 | 0.05 | Why? |
| Proteobacteria | 1 | 2018 | 36 | 0.05 | Why? |
| HLA-DR Antigens | 1 | 2021 | 563 | 0.05 | Why? |
| Pilot Projects | 2 | 2021 | 5182 | 0.05 | Why? |
| DNA, Ribosomal | 1 | 2018 | 112 | 0.05 | Why? |
| Congo | 1 | 2018 | 131 | 0.05 | Why? |
| Lipopolysaccharide Receptors | 1 | 2021 | 357 | 0.05 | Why? |
| Colony Count, Microbial | 1 | 2018 | 177 | 0.05 | Why? |
| Anaerobiosis | 1 | 2018 | 146 | 0.04 | Why? |
| Catalase | 1 | 2018 | 97 | 0.04 | Why? |
| Magnesium | 1 | 2021 | 290 | 0.04 | Why? |
| Severity of Illness Index | 6 | 2021 | 48226 | 0.04 | Why? |
| Asymptomatic Diseases | 2 | 2020 | 3444 | 0.04 | Why? |
| Odds Ratio | 2 | 2021 | 5861 | 0.04 | Why? |
| Oxidoreductases | 1 | 2018 | 136 | 0.04 | Why? |
| Microscopy, Electron | 1 | 2020 | 830 | 0.04 | Why? |
| Hospitalization | 7 | 2021 | 54280 | 0.04 | Why? |
| Mink | 1 | 2021 | 399 | 0.04 | Why? |
| Statistics, Nonparametric | 1 | 2020 | 1008 | 0.04 | Why? |
| Locomotion | 1 | 2018 | 130 | 0.04 | Why? |
| Chromosome Mapping | 1 | 2017 | 178 | 0.04 | Why? |
| Respiratory Rate | 1 | 2020 | 691 | 0.04 | Why? |
| Host-Pathogen Interactions | 1 | 2016 | 11041 | 0.04 | Why? |
| Case-Control Studies | 3 | 2021 | 17671 | 0.04 | Why? |
| Debridement | 1 | 2017 | 172 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Microscopy, Electron, Transmission | 1 | 2018 | 605 | 0.04 | Why? |
| Africa South of the Sahara | 1 | 2021 | 1335 | 0.04 | Why? |
| Epstein-Barr Virus Infections | 1 | 2020 | 366 | 0.04 | Why? |
| Molecular Sequence Annotation | 1 | 2018 | 478 | 0.04 | Why? |
| Patient Safety | 2 | 2021 | 4885 | 0.04 | Why? |
| Chloroquine | 2 | 2021 | 3152 | 0.04 | Why? |
| Molecular Epidemiology | 1 | 2021 | 1638 | 0.04 | Why? |
| Hydrogen-Ion Concentration | 1 | 2018 | 993 | 0.04 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.03 | Why? |
| Rhinovirus | 1 | 2020 | 979 | 0.03 | Why? |
| Endoscopy, Digestive System | 1 | 2018 | 352 | 0.03 | Why? |
| Nigeria | 1 | 2021 | 2292 | 0.03 | Why? |
| Proton Pump Inhibitors | 1 | 2018 | 377 | 0.03 | Why? |
| Interferon-alpha | 1 | 2021 | 1442 | 0.03 | Why? |
| Dysbiosis | 1 | 2019 | 685 | 0.03 | Why? |
| Sequence Deletion | 1 | 2017 | 674 | 0.03 | Why? |
| Colonoscopy | 1 | 2018 | 738 | 0.03 | Why? |
| HIV Infections | 1 | 2018 | 11620 | 0.03 | Why? |
| Follow-Up Studies | 2 | 2021 | 17020 | 0.03 | Why? |
| Lung | 1 | 2020 | 31049 | 0.03 | Why? |
| Prevalence | 3 | 2020 | 25773 | 0.03 | Why? |
| Smell | 1 | 2020 | 1851 | 0.03 | Why? |
| Age Distribution | 1 | 2020 | 3567 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2018 | 2275 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.03 | Why? |
| Turkey | 1 | 2021 | 3937 | 0.03 | Why? |
| Protein Conformation | 1 | 2021 | 4386 | 0.03 | Why? |
| Cluster Analysis | 1 | 2018 | 3001 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2021 | 3788 | 0.02 | Why? |
| Monitoring, Physiologic | 1 | 2021 | 1956 | 0.02 | Why? |
| Monocytes | 1 | 2021 | 2978 | 0.02 | Why? |
| Breast Feeding | 1 | 2019 | 1585 | 0.02 | Why? |
| Temperature | 1 | 2018 | 2305 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Seasons | 1 | 2020 | 4071 | 0.02 | Why? |
| Age Factors | 2 | 2020 | 21039 | 0.02 | Why? |
| Bariatric Surgery | 1 | 2018 | 1298 | 0.02 | Why? |
| Dyspnea | 1 | 2020 | 3847 | 0.02 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.02 | Why? |
| Models, Molecular | 1 | 2021 | 7616 | 0.02 | Why? |
| RNA, Messenger | 1 | 2021 | 5131 | 0.02 | Why? |
| Cough | 1 | 2020 | 4891 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2020 | 7220 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.02 | Why? |
| Hospitals, University | 1 | 2017 | 4173 | 0.02 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.02 | Why? |
| Databases, Factual | 1 | 2019 | 6248 | 0.02 | Why? |
| Tomography, X-Ray Computed | 2 | 2020 | 25144 | 0.02 | Why? |
| Fever | 1 | 2020 | 7795 | 0.02 | Why? |
| China | 2 | 2021 | 50654 | 0.02 | Why? |
| Viral Nonstructural Proteins | 1 | 2021 | 4810 | 0.02 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.02 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.01 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.01 | Why? |
| Symptom Assessment | 1 | 2016 | 4967 | 0.01 | Why? |
| Viral Proteins | 1 | 2021 | 7370 | 0.01 | Why? |
| Risk Factors | 2 | 2020 | 71621 | 0.01 | Why? |
| Epidemics | 1 | 2021 | 6407 | 0.01 | Why? |
| Brazil | 1 | 2017 | 12582 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Critical Illness | 1 | 2021 | 17281 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2018 | 22971 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Cross Infection | 1 | 2017 | 8675 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.01 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2016 | 8843 | 0.01 | Why? |
| United States | 1 | 2021 | 46150 | 0.01 | Why? |
| Global Health | 1 | 2017 | 13911 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2016 | 53120 | 0.01 | Why? |